GeneDx Cash from 2010 to 2025

WGSWW Stock   0.26  0.02  8.33%   
GeneDx Holdings Cash yearly trend continues to be fairly stable with very little volatility. Cash is likely to outpace its year average in 2025. Cash is the total amount of money in the form of currency that GeneDx Holdings Corp has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2010-12-31
Previous Quarter
85.2 M
Current Value
130.8 M
Quarterly Volatility
73.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Interest Income of 3.1 M, Depreciation And Amortization of 31.3 M or Interest Expense of 2.7 M, as well as many indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0 or PTB Ratio of 8.85. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.
  
Check out the analysis of GeneDx Holdings Correlation against competitors.

Latest GeneDx Holdings' Cash Growth Pattern

Below is the plot of the Cash of GeneDx Holdings Corp over the last few years. Cash refers to the most liquid asset of GeneDx Holdings Corp, which is listed under current asset account on GeneDx Holdings Corp balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from GeneDx Holdings customers. The amounts must be unrestricted with restricted cash listed in a different GeneDx Holdings account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. GeneDx Holdings' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Pretty Stable
   Cash   
       Timeline  

GeneDx Cash Regression Statistics

Arithmetic Mean126,853,208
Geometric Mean117,406,869
Coefficient Of Variation58.03
Mean Deviation34,708,363
Median108,132,000
Standard Deviation73,608,022
Sample Variance5418.1T
Range315.4M
R-Value0.20
Mean Square Error5565T
R-Squared0.04
Significance0.45
Slope3,144,753
Total Sum of Squares81272.1T

GeneDx Cash History

2025130.8 M
202485.2 M
202399.7 M
2022123.9 M
2021400.6 M

Other Fundumenentals of GeneDx Holdings Corp

GeneDx Holdings Cash component correlations

About GeneDx Holdings Financial Statements

GeneDx Holdings investors use historical fundamental indicators, such as GeneDx Holdings' Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeneDx Holdings. Please read more on our technical analysis and fundamental analysis pages.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.